Table of Contents Author Guidelines Submit a Manuscript
International Journal of Nephrology
Volume 2015, Article ID 301021, 8 pages
http://dx.doi.org/10.1155/2015/301021
Research Article

Hyperuricemia: An Early Marker for Severity of Illness in Sepsis

1Division of Nephrology, Department of Medicine, West Virginia University School of Medicine, Morgantown, WV, USA
2Division of Biostatistics, West Virginia University School of Medicine, Morgantown, WV, USA
3Division of Pulmonary and Critical Care Medicine, Department of Medicine, West Virginia University School of Medicine, Morgantown, WV, USA
4Department of Medicine, West Virginia University School of Medicine, Morgantown, WV, USA

Received 3 April 2015; Revised 29 June 2015; Accepted 15 July 2015

Academic Editor: Danuta Zwolinska

Copyright © 2015 Sana R. Akbar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. Doehner, N. Schoene, M. Rauchhaus et al., “Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies,” Circulation, vol. 105, no. 22, pp. 2619–2624, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. N. L. Edwards, “The role of hyperuricemia and gout in kidney and cardiovascular disease,” Cleveland Clinic Journal of Medicine, vol. 75, supplement 5, pp. S13–S16, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. A. G. Ioachimescu, D. M. Brennan, B. M. Hoar, S. L. Hazen, and B. J. Hoogwerf, “Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: a Preventive Cardiology Information System (PreCIS) database cohort study,” Arthritis and Rheumatism, vol. 58, no. 2, pp. 623–630, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. D. B. Corry and M. L. Tuck, “Uric acid and the vasculature,” Current Hypertension Reports, vol. 8, no. 2, pp. 116–119, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Patetsios, W. Rodino, W. Wisselink, D. Bryan, J. D. Kirwin, and T. F. Panetta, “Identification of uric acid in aortic aneurysms and atherosclerotic artery,” Annals of the New York Academy of Sciences, vol. 800, pp. 243–245, 1996. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Fang and M. H. Alderman, “Serum uric acid and cardiovascular mortality, the NHANES I epidemiologic follow up study, 1971–1992,” Journal of the American Medical Association, vol. 283, no. 18, pp. 2404–2410, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Verdecchia, G. Schillaci, G. Reboldi, F. Santeusanio, C. Porcellati, and P. Brunetti, “Relation between serum uric acid and risk of cardiovascular disease in essential hypertension: the PIUMA study,” Hypertension, vol. 36, no. 6, pp. 1072–1078, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Nakagawa, P. Cirillo, W. Sato et al., “The conundrum of hyperuricemia, metabolic syndrome, and renal disease,” Internal and Emergency Medicine, vol. 3, no. 4, pp. 313–318, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. L. G. Hunsicker, S. Adler, A. Caggiula et al., “Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study,” Kidney International, vol. 51, no. 6, pp. 1908–1919, 1997. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Iseki, S. Oshiro, M. Tozawa, C. Iseki, Y. Ikemiya, and S. Takishita, “Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects,” Hypertension Research, vol. 24, no. 6, pp. 691–697, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Leyva, S. Anker, J. W. Swan et al., “Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure,” European Heart Journal, vol. 18, no. 5, pp. 858–865, 1997. View at Publisher · View at Google Scholar · View at Scopus
  12. S. D. Anker, F. Leyva, P. A. Poole-Wilson, W. J. Kox, J. C. Stevenson, and A. J. S. Coats, “Relation between serum uric acid and lower limb blood flow in patients with chronic heart failure,” Heart, vol. 78, no. 1, pp. 39–43, 1997. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Braghiroli, C. Sacco, M. Erbetta, V. Ruga, and C. F. Donner, “Overnight urinary uric acid: creatinine ratio for detection of sleep hypoxemia: Validation study in chronic obstructive pulmonary disease and obstructive sleep apnea before and after treatment with nasal continuous positive airway pressure,” American Review of Respiratory Disease, vol. 148, no. 1, pp. 173–178, 1993. View at Publisher · View at Google Scholar · View at Scopus
  14. N. M. Elsayed, J. M. Nakashima, and E. M. Postlethwait, “Measurement of uric acid as a marker of oxygen tension in the lung,” Archives of Biochemistry and Biophysics, vol. 302, no. 1, pp. 228–232, 1993. View at Publisher · View at Google Scholar · View at Scopus
  15. N. L. Edwards, “The role of hyperuricemia and gout in kidney and cardiovascular disease,” Cleveland Clinic Journal of Medicine, vol. 75, no. 5, pp. 13–16, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Mazzali, J. Kanellis, L. Han et al., “Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism,” The American Journal of Physiology—Renal Physiology, vol. 282, no. 6, pp. F991–F997, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. H. J. Han, M. J. Lim, Y. J. Lee, J. H. Lee, I. S. Yang, and M. Taub, “Uric acid inhibits renal proximal tubule cell proliferation via at least two signaling pathways involving PKC, MAPK, cPLA2, and NF-κB,” American Journal of Physiology—Renal Physiology, vol. 292, no. 1, pp. F373–F381, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. M. G. Netea, B. J. Kullberg, W. L. Blok, R. T. Netea, and J. W. M. Van der Meer, “The role of hyperuricemia in the increased cytokine production after lipopolysaccharide challenge in neutropenic mice,” Blood, vol. 89, no. 2, pp. 577–582, 1997. View at Google Scholar · View at Scopus
  19. D. H. Kang, T. Nakagawa, L. Feng et al., “A role for uric acid in the progression of renal disease,” Journal of the American Society of Nephrology, vol. 13, no. 12, pp. 69–78, 2002. View at Google Scholar
  20. M. Mazzali, J. Hughes, Y.-G. Kim et al., “Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism,” Hypertension, vol. 38, no. 5, pp. 1101–1106, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. L. G. Sánchez-Lozada, E. Tapia, R. López-Molina et al., “Effects of acute and chronic L-arginine treatment in experimental hyperuricemia,” The American Journal of Physiology—Renal Physiology, vol. 292, no. 4, pp. F1238–F1244, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Zharikov, K. Krotova, H. Hu et al., “Uric acid decreases NO production and increases arginase activity in cultured pulmonary artery endothelial cells,” The American Journal of Physiology—Cell Physiology, vol. 295, no. 5, pp. C1183–C1190, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Gersch, S. P. Palii, K. M. Kim, A. Angerhofer, R. J. Johnson, and G. N. Henderson, “Inactivation of nitric oxide by uric acid,” Nucleosides, Nucleotides and Nucleic Acids, vol. 27, no. 8, pp. 967–978, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. B. N. Ames, R. Cathcart, E. Schwiers, and P. Hochstein, “Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 78, no. 11, pp. 6858–6862, 1981. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Zarjou and A. Agarwal, “Sepsis and acute kidney injury,” Journal of the American Society of Nephrology, vol. 22, no. 6, pp. 999–1006, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Dellinger, M. Levy, A. Rhodes et al., “Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock,” Critical Care Medicine, vol. 41, no. 2, pp. 580–637, 2013. View at Google Scholar
  27. A. Khwaja, “KDIGO clinical practice guidelines for acute kidney injury,” Nephron Clinical Practice, vol. 120, no. 4, pp. c179–c184, 2012. View at Publisher · View at Google Scholar
  28. W. A. Knaus, E. A. Draper, D. P. Wagner, and J. E. Zimmerman, “APACHE II: a severity of disease classification system,” Critical Care Medicine, vol. 13, no. 10, pp. 818–829, 1985. View at Publisher · View at Google Scholar · View at Scopus
  29. V. M. Ranieri, G. D. Rubenfeld, B. T. Thompson et al., “Acute respiratory distress syndrome. The Berlin definition,” Journal of the American Medical Association, vol. 307, no. 23, pp. 2526–2533, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. H. C. Cowley, P. J. Bacon, H. F. Goode, N. R. Webster, J. G. Jones, and D. K. Menon, “Plasma antioxidant potential in severe sepsis: a comparison of survivors and non-survivors,” Critical Care Medicine, vol. 24, no. 7, pp. 1179–1183, 1996. View at Publisher · View at Google Scholar · View at Scopus
  31. J. M. Alonso de Vega, J. Díaz, E. Serrano, and L. F. Carbonell, “Oxidative stress in critically ill patients with systemic inflammatory response syndrome,” Critical Care Medicine, vol. 30, no. 8, pp. 1782–1786, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. J. M. Alonso de Vega, J. Díaz, E. Serrano, and L. F. Carbonell, “Plasma redox status relates to severity in critically ill patients,” Critical Care Medicine, vol. 28, no. 6, pp. 1812–1814, 2000. View at Publisher · View at Google Scholar · View at Scopus
  33. C. Pascual, W. Karzai, A. Meier-Hellmann et al., “Total plasma antioxidant capacity is not always decreased in sepsis,” Critical Care Medicine, vol. 26, no. 4, pp. 705–709, 1998. View at Publisher · View at Google Scholar · View at Scopus
  34. K. L. MacKinnon, Z. Molnar, D. Lowe, I. D. Watson, and E. Shearer, “Measures of total free radical activity in critically ill patients,” Clinical Biochemistry, vol. 32, no. 4, pp. 263–268, 1999. View at Publisher · View at Google Scholar · View at Scopus
  35. R.-J. Teng, Y.-Z. Ye, D. A. Parks, and J. S. Beckman, “Urate produced during hypoxia protects heart proteins from peroxynitrite-mediated protein nitration,” Free Radical Biology and Medicine, vol. 33, no. 9, pp. 1243–1249, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Meneshian and G. B. Bulkley, “The physiology of endothelial xanthine oxidase: from urate catabolism to reperfusion injury to inflammatory signal transduction,” Microcirculation, vol. 9, no. 3, pp. 161–175, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. L. S. Terada, D. M. Guidot, J. A. Leff et al., “Hypoxia injures endothelial cells by increasing endogenous xanthine oxidase activity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 8, pp. 3362–3366, 1992. View at Publisher · View at Google Scholar · View at Scopus
  38. G. M. Chertow, J. M. Lazarus, C. L. Christiansen et al., “Preoperative renal risk stratification,” Circulation, vol. 95, no. 4, pp. 878–884, 1997. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Hilberman, B. D. Myers, B. J. Carrie, G. Derby, R. L. Jamison, and E. B. Stinson, “Acute renal failure following cardiac surgery,” Journal of Thoracic and Cardiovascular Surgery, vol. 77, no. 6, pp. 880–888, 1979. View at Google Scholar · View at Scopus
  40. L. G. Sánchez-Lozada, E. Tapia, J. Santamaría et al., “Mild hyperuricemia induces glomerular hypertension in normal rats,” The American Journal of Physiology—Renal Physiology, vol. 283, no. 5, pp. F1105–F1110, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. U. M. Khosla, S. Zharikov, J. L. Finch et al., “Hyperuricemia induces endothelial dysfunction,” Kidney International, vol. 67, no. 5, pp. 1739–1742, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. C. Zoccali, R. Maio, F. Mallamaci, G. Sesti, and F. Perticone, “Uric acid and endothelial dysfunction in essential hypertension,” Journal of the American Society of Nephrology, vol. 17, no. 5, pp. 1466–1471, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Chonchol, M. G. Shlipak, R. Katz et al., “Relationship of uric acid with progression of kidney disease,” The American Journal of Kidney Diseases, vol. 50, no. 2, pp. 239–247, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. M. E. Suliman, R. J. Johnson, E. García-López et al., “J-shaped mortality relationship for uric acid in CKD,” American Journal of Kidney Diseases, vol. 48, no. 5, pp. 761–771, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. C. M. Jabs, G. H. Sigurdsson, and P. Neglen, “Plasma levels of high-energy compounds compared with severity of illness in critically ill patients in the intensive care unit,” Surgery, vol. 124, no. 1, pp. 65–72, 1998. View at Publisher · View at Google Scholar · View at Scopus
  46. C.-C. Chuang, S.-C. Shiesh, C.-H. Chi et al., “Serum total antioxidant capacity reflects severity of illness in patients with severe sepsis,” Critical Care, vol. 10, no. 1, article R36, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. N. Nagaya, M. Uematsu, T. Satoh et al., “Serum uric acid levels correlate with the severity and the mortality of primary pulmonary hypertension,” American Journal of Respiratory and Critical Care Medicine, vol. 160, no. 2, pp. 487–492, 1999. View at Publisher · View at Google Scholar · View at Scopus